Treatment program in MGH

We integrate compassionate care with innovative research and rigorous medical training. Our subspecialty care is aided by the latest technology, from life-saving intervention for acute brain trauma to expert management of chronic illnesses.
    3911 results
    • staff story

    From the Bench- The Lab of Dr. Ghazaleh Sadri-Vakili

    At the Sean M. Healey & AMG Center for ALS, compassionate clinical care converges with cutting-edge research every day. The laboratories at the Charlestown Navy Yard are humming with investigators researching the latest breakthroughs in ALS and bringing us closer to a cure.

    • news

    Research Spotlight: Orthopaedic Surgery Volume Trends During the COVID-19 Pandemic and Post-Vaccination Era

    Marc Succi, MD, a physician investigator in the Department of Radiology at Massachusetts General Hospital, associate chair of innovation and commercialization at Mass General Brigham Enterprise Radiology and an assistant professor of Radiology at Harvard Medical School, is the lead author of a recently published paper in Journal of Arthplasty, Orthopaedic Surgery Volume Trends During the COVID-19 Pandemic and Post-Vaccination Era: Implications for Healthcare Planning

    • news

    Research Spotlight: How inflammation damages synapses in an experimental model of multiple sclerosis

    Rebecca Gillani, MD, PhD, a physician investigator in the Department of Neurology at Massachusetts General Hospital and an Instructor in Neurology at Harvard Medical School, is the lead author of a recently published paper in Brain, Behavior, and Immunity; Instability of Excitatory Synapses in Experimental Autoimmune Encephalomyelitis and the Outcome for Excitatory Circuit Inputs To Individual Cortical Neurons.

    • news

    Research Spotlight: What are Special Purpose Acquisition Companies in the US Healthcare System?

    Zirui Song, MD, PhD, a physician investigator in the Department of Medicine at Massachusetts General Hospital and an associate professor of Health Care Policy and Medicine at Harvard Medical School, is the senior author of a recently published perspective in the New England Journal of Medicine, Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States. The article’s lead author is Nishant Uppal, MD, MBA, a resident at Brigham and Women’s Hospital.

    • press release

    Clinical trial shows that cytisinicline can help people quit vaping

    In a randomized clinical trial including adults who vaped nicotine e-cigarettes but did not smoke cigarettes, a 12-week course of cytisinicline, a plant-based medication, was more effective at helping people quit e-cigarettes than placebo when both were combined with behavioral support.

    Showing 1 - 10 of 3911 results